2025-05-27 - Analysis Report
Okay, here's a report analyzing Hims & Hers Health Inc (HIMS) based on the data you provided.

## Hims & Hers Health Inc (HIMS) Stock Analysis

**Company Overview:** Hims & Hers Health Inc is a telehealth company offering a variety of health and wellness products and services directly to consumers.

### 1. Performance vs. S&P 500 (VOO)

*   **HIMS Cumulative Return:** 269.50%
*   **VOO Cumulative Return:** 47.83%
*   **Absolute Deviation:** 221.7%
*   **Relative Deviation:** 81.8%

**Analysis:**

HIMS has significantly outperformed the S&P 500 (VOO) over the period examined. The large relative deviation (81.8%) indicates that HIMS' performance is near the high end of its historical range compared to the S&P 500. This suggests strong growth or outperformance relative to the broader market but could also indicate a potential for mean reversion.

**Alpha/Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha  | Beta   | Cap(B) |
| ---------- | ------ | ------ | ------ | ------ | ------ |
| 2019-2021  | -46.0% | 51.0%  | -90.0% | -0.0   | 1.5    |
| 2020-2022  | -15.0% | 72.1%  | -21.0% | -0.0   | 1.4    |
| 2021-2023  | -51.0% | 72.1%  | -68.0% | -0.1   | 2.0    |
| 2022-2024  | 127.0% | 78.4%  | 110.0% | -0.2   | 5.4    |
| 2023-2025  | 265.0% | 78.4%  | 237.0% | -0.1   | 12.3   |

**Analysis:**

*   **CAGR:** The Compounded Annual Growth Rate (CAGR) shows a dramatic turnaround, shifting from negative growth in previous periods to explosive growth in the recent 2022-2025 period (265%).
*   **MDD:** The Maximum Drawdown (MDD) remains high, indicating significant volatility and potential for large declines.
*   **Alpha:** Alpha has turned positive and very high in recent periods, suggesting HIMS is generating significant excess returns relative to its benchmark.
*   **Beta:** The consistently negative Beta suggests that HIMS has a negative correlation with the market, meaning it may move in the opposite direction to the S&P 500. However, the values are close to zero, making this interpretation less reliable.
*   **Cap(B):** The Market Capitalization has increased significantly, reflecting investor confidence and company growth.

### 2. Recent Price Action

*   **Current Price:** 54.83
*   **Previous Close:** 53.52
*   **Change:** 2.45
*   **5-Day Moving Average:** 57.98
*   **20-Day Moving Average:** 50.706
*   **60-Day Moving Average:** 38.0872

**Analysis:**

The stock price has increased significantly from the previous close. The current price is below the 5-day moving average but above the 20-day and 60-day moving averages. This suggests a possible short-term pullback after a strong upward trend. The recent jump in price likely reflects the business developments, regulatory changes, and market events mentioned in the news.

### 3. Technical Indicators

*   **Market Risk Indicator (MRI):** 0.366 (Low Risk)
*   **RSI:** 63.50 (Approaching Overbought)
*   **PPO:** -1.58
*   **Hybrid Signal:** cash_70%_Sell 0.6% of holdings
*   **Delta_Previous_Relative_Divergence:** -18.2 (Negative, Short-Term Decline)
*   **Expected Return:** -10.4%

**Analysis:**

*   The MRI indicates a low-risk environment for the stock.
*   The RSI is approaching overbought territory, suggesting the stock may be due for a correction.
*   The negative PPO indicates that the short-term moving average is below the long-term moving average, suggesting a downward trend.
*   The Hybrid Signal suggests a cautious approach, recommending selling a small portion of holdings.
*   The negative Delta_Previous_Relative_Divergence confirms a recent short-term decline.
*   The negative Expected Return suggests that HIMS may underperform the S&P 500 over the long term if purchased at the current price.

### 4. Recent News & Events

*   **Business Developments/Regulatory Changes/Market Events:** Hims & Hers Health Inc has recently been in the news due to significant business developments, regulatory changes, or market events.
*   **Analyst Discussions:** Analysts are discussing Hims & Hers Health Inc's recent performance and outlook in the context of industry trends and global economic factors.
*   **Stock Volatility:** Hims & Hers Health Inc's stock has shown notable volatility, influenced by recent news, earnings reports, or executive actions.
*   **Expert Advice:** Market experts highlight both risks and opportunities for Hims & Hers Health Inc, advising investors to monitor recent news and company announcements.

**Analysis:**

Recent news indicates that HIMS is experiencing significant activity, including business developments, regulatory changes, and market events. These factors are contributing to stock volatility and warrant close monitoring.

### 5. Recent Earnings Analysis:

| Date       | EPS  | Revenue   |
| ---------- | ---- | --------- |
| 2025-05-05 | 0.22 | 0.59 B$   |
| 2024-11-04 | 0.35 | 0.40 B$   |
| 2024-08-05 | 0.06 | 0.32 B$   |
| 2024-05-06 | 0.05 | 0.28 B$   |
| 2025-05-05 | 0.05 | 0.28 B$   |

**Analysis:**

*   **EPS:** Earnings Per Share (EPS) has shown volatility but generally positive performance.
*   **Revenue:** Revenue is demonstrating a clear upward trend. This indicates strong growth in the company's business.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
| ---------- | --------- | ------------- |
| 2025-03-31 | $0.59B    | 73.50%        |
| 2024-12-31 | $0.48B    | 76.81%        |
| 2024-09-30 | $0.40B    | 79.16%        |
| 2024-06-30 | $0.32B    | 81.30%        |
| 2024-03-31 | $0.28B    | 82.36%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE   |
| ---------- | --------- | ----- |
| 2025-03-31 | $0.55B    | 9.01% |
| 2024-12-31 | $0.48B    | 5.46% |
| 2024-09-30 | $0.44B    | 17.18% |
| 2024-06-30 | $0.36B    | 3.67% |
| 2024-03-31 | $0.34B    | 3.23% |

**Analysis:**

*   **Revenue:** Revenue has consistently increased over the past five quarters.
*   **Profit Margin:** The profit margin has decreased slightly in the latest quarter, which could be a point of concern.
*   **Equity:** Equity has shown growth over the past quarters.
*   **ROE:** The Return on Equity (ROE) has fluctuated, with a peak in 2024-09-30.

### 7. Overall Analysis

HIMS has demonstrated significant outperformance compared to the S&P 500, driven by strong revenue growth and improving earnings. However, the stock exhibits high volatility, and recent technical indicators suggest a possible short-term pullback. The upcoming business developments, regulatory changes, and market events warrant close monitoring. While the long-term expected return is negative, the company's growth trajectory and recent positive financial performance make it an interesting investment with both opportunities and risks. Investors should carefully consider their risk tolerance and investment horizon before investing in HIMS.

**Key Takeaways:**

*   **High Growth:** HIMS is experiencing rapid growth, evidenced by its revenue increases and significant outperformance compared to the S&P 500.
*   **High Volatility:** The stock exhibits significant volatility, as indicated by the high MDD and recent price fluctuations.
*   **Mixed Signals:** Technical indicators provide mixed signals, with some suggesting a potential pullback and others indicating continued positive momentum.
*   **Positive Fundamentals:** The company's fundamentals are improving, with increasing revenue and a positive trend in earnings.
*   **Monitor Closely:** Investors should closely monitor upcoming news, earnings reports, and market events to assess the stock's future performance.

